Moxsh Overseas Educon Ltd

Moxsh Overseas Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Moxsh Overseas Educon Ltd

₹ 140 4.59%
12 May - close price
moksh16.com NSE - SME: MOXSH
About

Incorporated in 2018, Moxsh Overseas Educon Ltd provides counselling, guidance, and online coaching for Indian and international students[1]

Key Points

Business Overview:[1]
MOEL provides coaching to medical aspirants in 7 countries including India. Further, it aims to launch India’s first chain of primary healthcare clinics as Edu-Clinics operated by doctors

Website NSE - ST
  • Market Cap ₹ 131 Cr.
  • Current Price ₹ 140
  • High / Low ₹ 140 / 27.0
  • Stock P/E
  • Book Value ₹ 9.07
  • Dividend Yield 0.00 %
  • ROCE 4.76 %
  • ROE 0.20 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 141 days to 95.2 days

Cons

  • Stock is trading at 15.4 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -2.39%
  • The company has delivered a poor sales growth of 3.48% over past five years.
  • Company has a low return on equity of -4.16% over last 3 years.
  • Company has high debtors of 314 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Other Consumer Services Education

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
9.17 5.24 7.02 7.84 2.80 5.70 3.96 2.29
5.68 4.92 5.35 7.16 5.83 4.99 3.50 4.04
Operating Profit 3.49 0.32 1.67 0.68 -3.03 0.71 0.46 -1.75
OPM % 38.06% 6.11% 23.79% 8.67% -108.21% 12.46% 11.62% -76.42%
0.00 0.00 0.04 0.03 0.42 0.04 0.20 0.03
Interest 0.04 0.10 0.24 0.16 0.15 0.28 0.38 0.41
Depreciation 0.17 0.19 0.13 0.30 0.31 0.35 0.33 0.60
Profit before tax 3.28 0.03 1.34 0.25 -3.07 0.12 -0.05 -2.73
Tax % 12.20% -133.33% 30.60% 28.00% -20.52% 0.00% 100.00% -25.64%
2.88 0.08 0.93 0.18 -2.44 0.12 -0.11 -2.03
EPS in Rs 20.57 0.13 1.03 0.20 -2.71 0.13 -0.12 -2.26
Raw PDF
Upcoming result date: 22 May 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
8.14 3.86 10.08 12.27 10.64 9.66 6.25
7.85 3.66 8.19 10.28 12.93 8.49 7.54
Operating Profit 0.29 0.20 1.89 1.99 -2.29 1.17 -1.29
OPM % 3.56% 5.18% 18.75% 16.22% -21.52% 12.11% -20.64%
0.04 0.00 -0.03 0.04 0.40 0.24 0.23
Interest 0.01 0.04 0.07 0.23 0.31 0.62 0.79
Depreciation 0.02 0.08 0.30 0.43 0.61 0.72 0.93
Profit before tax 0.30 0.08 1.49 1.37 -2.81 0.07 -2.78
Tax % 30.00% 37.50% 26.85% 27.01% -19.93% 71.43%
0.22 0.05 1.09 1.01 -2.25 0.02 -2.14
EPS in Rs 11.00 2.50 7.79 1.12 -2.50 0.02 -2.38
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 3%
3 Years: -1%
TTM: -26%
Compounded Profit Growth
10 Years: %
5 Years: -38%
3 Years: -74%
TTM: 8%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 57%
1 Year: 418%
Return on Equity
10 Years: %
5 Years: 0%
3 Years: -4%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.05 0.06 0.36 2.24 2.24 8.96 8.96
Reserves 0.22 0.29 1.11 10.16 7.91 1.20 -0.83
0.35 0.00 0.44 1.69 3.31 5.40 6.41
0.63 1.10 2.96 1.81 2.07 1.69 2.28
Total Liabilities 1.25 1.45 4.87 15.90 15.53 17.25 16.82
0.19 1.02 1.56 2.04 1.77 2.50 5.40
CWIP 0.08 0.04 0.05 0.09 1.69 1.65 0.00
Investments 0.00 0.00 0.01 0.01 0.01 0.01 0.01
0.98 0.39 3.25 13.76 12.06 13.09 11.41
Total Assets 1.25 1.45 4.87 15.90 15.53 17.25 16.82

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.16 1.13 0.53 -7.86 -2.27 -0.35
-0.24 -0.87 -0.86 -3.17 0.74 -1.28
0.34 -0.36 0.44 11.03 1.47 1.62
Net Cash Flow -0.06 -0.10 0.11 0.00 -0.07 -0.01
Free Cash Flow -0.44 0.26 -0.32 -8.79 -2.57 -1.76
CFO/OP 14% 565% 21% -357% 97% -30%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 0.00 4.73 78.21 210.02 273.41 313.99
Inventory Days
Days Payable
Cash Conversion Cycle 0.00 4.73 78.21 210.02 273.41 313.99
Working Capital Days -5.38 -54.84 -26.80 219.54 107.72 95.22
ROCE % 24.74% 141.59% 20.00% -17.86% 4.76%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025 Mar 2026
Annual Student Inquiries
Number

Log in to view insights

Please log in to see hidden values.

Login
Employee Strength
Number
Target Placements (Europe Non-Medical/VET)
Number
Company Owned Studium Centers
Number
Ed-Tech Division Revenue Contribution
Percentage
Franchisee/Edu-Clinic Agreements
Number
Market Share (Medicine Abroad)
Percentage
Onboarded B2B Agents (XERA Platform)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Sep 2023Mar 2024Sep 2024Oct 2024Mar 2025Sep 2025Mar 2026
61.61% 61.61% 61.61% 62.43% 62.43% 62.43% 62.43% 62.43% 60.04%
0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.46% 0.00%
38.35% 38.40% 38.39% 37.57% 37.57% 37.57% 37.57% 37.11% 39.96%
No. of Shareholders 733614410343258253252241210

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports